Who to call at Elite Pharmaceuticals, Inc., and when
Fundz watches for the moments Elite Pharmaceuticals, Inc. starts buying, and tells you who to reach.
- An alert the day Elite Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elite Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elite Pharmaceuticals, Inc.. With Fundz connected, it knows.
Elite Pharmaceuticals, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
elitepharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Elite Pharmaceuticals expanded its Board of Directors from four to six members by electing Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq., on October 28, 2026. Both directors bring significant pharmaceutical industry experience and will receive standard non-management director compensation.
Key Takeaways
Board size increased from 4 to 6 directors, signaling potential strategic expansion or governance strengthening
Dr. Fatmi brings 40+ years of pharmaceutical industry experience including advisory roles at major firms like BlackRock/Tennenbaum and Strides Pharma
3 more takeaways
Filing Overview
What This Means
Elite Pharmaceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.